NCICB Seeks Comment on Data Standards Draft
The National Cancer Institute Center for Bioinformatics has released for public comment a draft document covering data content standards for clinical and basic science.
NCICB said it commissioned SAIC to review current data content standards in order to prepare the draft, which is available for a two-week public comment period at ftp://ftp1.nci.nih.gov/pub/cacore/ExternalStds/.
NCICB said it plans to incorporate comments and to release a final version of the document by the end of June.
Geospiza Partners with AME, Biomax
Geospiza last week announced reseller partnerships with AME Bioscience and Biomax Solutions.
In the AME deal, Geospiza’s Finch Sequencing Center software system will be bundled with refurbished or pre-owned sequencing instruments from Applied Biosystems and Amersham Bioscience (Now GE Healthcare).
Under the Biomax agreement, the firms will integrate sell their software together in a package called the Optimized Research Environment.
Oracle Holds Life Science User Group Meeting
Oracle will be hosting its fourth Oracle Life Sciences Users Group Meeting, June 23-24 in Reston, Va.
A full agenda and registration information are available at http://otn.oracle.com/industries/life_sciences/olsug/olsug_june2004.html.
NCI, FDA Host Biomarker Validation Workshop
The National Cancer Institute and the Food and Drug Administration will host a workshop in Bethesda, Md., on July 28-29 called, “Research Strategies, Study Designs and Statistical Approaches to Biomarkers Validation for Cancer Diagnosis and Detection.”
The workshop will address study design, statistical methodologies, and validation approaches to cancer biomarkers, and consider approaches to their validation for clinical utility.
A major goal of the workshop, according to the organizers, is “to develop a position paper on state-of-the-art in biomarker validation study.”
Additional information is available at http://www.scgcorp.com/biomarkers2004/.